Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07268742

Free Vitamin D and Steroid Metabolism in Endocrine Disorders

Free Fraction Vitamin D Measurements to Improve Understanding of Steroid Metabolism in Endocrine Disorders

Status
Recruiting
Phase
Study type
Observational
Enrollment
930 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This clinical study aims to gain a better understanding of how different forms of vitamin D are processed in the body in healthy individuals, pregnant women, and patients with various hormonal (endocrine) and kidney (renal) disorders. In the long term, this study may provide new insights that could how vitamin D is tested and interpreted in these groups. Vitamin D has several important roles in the body, such as building strong bones and maintaining calcium balance in the blood. Most vitamin D in the blood circulation is attached/bound to a protein called "vitamin D binding protein" (VDBP), which makes it unavailable for the body to use. A much smaller portion circulates freely in the blood and this is called "free vitamin D". This free form can be directly used by the body. When your doctor tests your vitamin D levels, this usually refers to total vitamin D (the sum of bound and free vitamin D). However, this total value may not give an accurate indication of your actual vitamin D status, since most of it (the bound part) cannot be used by the body. The purpose of this study is to examine whether "free vitamin D" is a better marker of vitamin D status and if the amount of free vitamin D differs between healthy people, pregnant women, and people with specific endocrine or kidney disorders. Additionally, this study will look into vitamin D metabolism more detailed, and investigate what different forms of vitamin D exist, how the body processes these, and whether these forms may be related to certain endocrine or kidney conditions.

Conditions

Interventions

TypeNameDescription
OTHERBlood draw for the laboratory assessmentBlood draw for the laboratory assessment

Timeline

Start date
2024-06-01
Primary completion
2029-10-01
Completion
2029-10-01
First posted
2025-12-08
Last updated
2025-12-08

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT07268742. Inclusion in this directory is not an endorsement.